We are live on ! Find out more
GD

Grandfield & Dodd Portfolio holdings

AUM $1.77B
1-Year Est. Return 23.43%
This Fund
S&P 500
This Quarter Est. Return
+5.12%
1 Year Est. Return
+23.43%
3 Year Est. Return
+55.25%
5 Year Est. Return
+78.92%
10 Year Est. Return
+317.48%
AUM
$1.43B
AUM Growth
-$302K
Cap. Flow
-$60.8M
Cap. Flow %
-4.25%
Top 10 Hldgs %
31.08%
Holding
196
New
6
Increased
45
Reduced
100
Closed
3

Top Buys

Rank Stock Value
1
GEHC icon
GE HealthCare
GEHC
+$3.38M
2
GE icon
GE Aerospace
GE
+$3.1M
3
PYPL icon
PayPal
PYPL
+$1.78M
4
ALB icon
Albemarle
ALB
+$1.12M
5
MUB icon
iShares National Muni Bond ETF
MUB
+$675K

Top Sells

Rank Stock Value
1
ABB
ABB Ltd
ABB
+$31.5M
2
XOM icon
ExxonMobil
XOM
+$5.35M
3
ALL icon
Allstate
ALL
+$3.34M
4
CVX icon
Chevron
CVX
+$3.3M
5
VMC icon
Vulcan Materials
VMC
+$2.41M

Sector Composition

Rank Sector Weight
1 Technology 27.5%
2 Healthcare 17.79%
3 Industrials 14.57%
4 Financials 9.65%
5 Materials 9.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMGN icon
76
Amgen
AMGN
$208B
$2.09M 0.15%
9,393
-996
-10% -$231K
AMZN icon
77
Amazon
AMZN
$2.92T
$1.87M 0.13%
14,367
+2,666
+23% +$304K
NTR icon
78
Nutrien
NTR
$33.2B
$1.83M 0.13%
30,960
SPY icon
79
State Street SPDR S&P 500 ETF Trust
SPY
$790B
$1.79M 0.13%
4,033
+40
+1% +$16.8K
HON icon
80
Honeywell
HON
$77B
$1.77M 0.12%
9,043
+49
+0.5% +$9.1K
VEU icon
81
Vanguard FTSE All-World ex-US ETF
VEU
$66.6B
$1.72M 0.12%
31,663
-963
-3% -$52.2K
HD icon
82
Home Depot
HD
$331B
$1.7M 0.12%
5,488
+74
+1% +$21.9K
ABT icon
83
Abbott
ABT
$183B
$1.61M 0.11%
14,795
-312
-2% -$33.3K
CL icon
84
Colgate-Palmolive
CL
$73.1B
$1.6M 0.11%
20,757
FAST icon
85
Fastenal
FAST
$54.7B
$1.58M 0.11%
53,700
-620
-1% -$17K
LLY icon
86
Eli Lilly
LLY
$1.02T
$1.47M 0.1%
3,141
-160
-5% -$67.1K
ISRG icon
87
Intuitive Surgical
ISRG
$127B
$1.46M 0.1%
4,272
+11
+0.3% +$3.33K
ALL icon
88
Allstate
ALL
$68B
$1.45M 0.1%
13,331
-29,410
-69% -$3.34M
NBIX icon
89
Neurocrine Biosciences
NBIX
$16.8B
$1.44M 0.1%
15,255
+77
+0.5% +$7.52K
ADP icon
90
Automatic Data Processing
ADP
$106B
$1.42M 0.1%
6,453
-200
-3% -$43.1K
BMRN icon
91
BioMarin Pharmaceuticals
BMRN
$11.6B
$1.37M 0.1%
15,778
+137
+0.9% +$12.9K
IVV icon
92
iShares Core S&P 500 ETF
IVV
$878B
$1.37M 0.1%
3,064
+150
+5% +$63.2K
ORCL icon
93
Oracle
ORCL
$374B
$1.36M 0.09%
11,400
+54
+0.5% +$5.58K
IONS icon
94
Ionis Pharmaceuticals
IONS
$8.6B
$1.34M 0.09%
32,679
+395
+1% +$15.2K
EMR icon
95
Emerson Electric
EMR
$83.9B
$1.29M 0.09%
14,250
-800
-5% -$67.3K
CTRA
96
DELISTED
Coterra Energy
CTRA
$1.27M 0.09%
50,104
VV icon
97
Vanguard Morningstar Large-Cap ETF
VV
$52.4B
$1.26M 0.09%
6,225
MMM icon
98
3M
MMM
$90.9B
$1.13M 0.08%
13,511
-1,109
-8% -$94.2K
MCD icon
99
McDonald's
MCD
$192B
$1.11M 0.08%
3,722
+9
+0.2% +$2.62K
INCY icon
100
Incyte
INCY
$24.2B
$1.1M 0.08%
17,606
+211
+1% +$14.1K

Similar funds

Grandfield & Dodd's Q2 2023 Portfolio in Review

As of Q2 2023, Grandfield & Dodd held 196 positions worth $1.43B, down 0.02% from $1.43B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Grandfield & Dodd withdrew a net $60.8M in Q2 2023, closing 3 positions and reducing 100 holdings. Its most notable exit was ABB Ltd, an estimated $31.5M position sold in full.

By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 28% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Grandfield & Dodd opened a new position in iShares National Muni Bond ETF worth $674K.

  • Grandfield & Dodd's largest Q2 2023 buy was iShares National Muni Bond ETF: 6,312 shares worth $674K.
  • Grandfield & Dodd added most to GE HealthCare in Q2 2023, an estimated $3.38M increase.
  • Grandfield & Dodd's biggest Q2 2023 reduction was ExxonMobil, cutting an estimated $5.35M.
  • Grandfield & Dodd fully exited ABB Ltd in Q2 2023, selling an estimated $31.5M.
  • Grandfield & Dodd's ten largest holdings make up 31% of its $1.43B portfolio in Q2 2023.
  • Grandfield & Dodd opened 6 new positions and closed 3 in Q2 2023.
  • Grandfield & Dodd's portfolio value fell 0.02% quarter-over-quarter to $1.43B.

Based on Grandfield & Dodd's 13F filing for Q2 2023, filed 8 Aug 2023.